IMR Press / CEOG / Volume 14 / Issue 1 / pii/1634257464528-1578310562

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Steroid receptors in benign breast disease, gross cystic disease and fibroadenoma
Show Less
1 Institute of Obstetric and Gynaecology, University of Padua (Italy)
Clin. Exp. Obstet. Gynecol. 1987, 14(1), 10–15;
Published: 10 March 1987
Abstract

The benign breast pathology embraces a wide variety of anatomo-clinical-pathological conditions producing confusion in nomenclature. The Authors collected three different types of BBP and investigated the hormonal receptor status for each. The following concentrations of ERc were found: 1-6 fmol/mg in BBD; less than 2 fmol/mg in GCD; 12-18 fmol/mg in the cytoplasm and 29-37.5 fmol/mg in the nucleus in FA. In FA, PgR was found in concentrations of 43.5-50 fmol/mg in the cytoplasm and 0.2-10 fmol/mg in the nucleus. Even if we consider these three histopathological entities (BBD, GCD, FA) separately, no correlation can be seen between the presence of receptors and benign breast disease. The only observation we can make is that the fibroadenomas contain more easily identificable receptor con-centrations than BBD and GCD.
Keywords
Receptors
Benign breast disease
Share
Back to top